Market Tracker

09/23 5:16pm ET

Biogen Inc (NASDAQ:BIIB)

312.58
Delayed Data
As of Sep 23
 -2.23 / -0.71%
Today’s Change
223.02
Today|||52-Week Range
333.65
+2.03%
Year-to-Date

Today’s Trading

Previous close314.81
Today’s open312.58
Day’s range312.11 - 317.32
Volume881,641
Average volume (3 months)1,887,785
Market cap$68.5B
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+24.01%
Earnings growth (this year)+16.59%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)-3.87%
P/E ratio18.2
Price/Sales7.60
Price/Book7.29

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.15-0.18%
ILMNIllumina Inc-0.01-0.01%
AMGNAmgen-0.82-0.47%
NBIXNeurocrine Bioscienc...-0.22-0.41%
Data as of 4:14pm ET, 09/23/2016

Financials

Next reporting dateOctober 26, 2016
EPS forecast (this quarter)$5.02
Annual revenue (last year)$9.3B
Annual profit (last year)$3.5B
Net profit margin38.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
George A. Scangos
Chief Scientific Officer &
Executive VP
Spyridon Artavanis-Tsakonas
Corporate headquarters
Cambridge, Massachusetts

Forecasts